Biomarkers and endpoints for dry AMD trials

被引：0
|
作者：
Sadda, Srinivas R. [1 ,2 ]
机构：
[1] Doheny Eye Inst, 1355 San Pablo St, Los Angeles, CA 90033 USA
[2] Univ Calif Los Angeles, Ophthalmol, Los Angeles, CA USA
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2019年 / 60卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
991
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Biomarkers and surrogate endpoints in clinical trials
    Fleming, Thomas R.
    Powers, John H.
    STATISTICS IN MEDICINE, 2012, 31 (25) : 2973 - 2984
  • [2] Biomarkers and surrogate endpoints in glaucoma clinical trials
    Medeiros, Felipe A.
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2015, 99 (05) : 599 - 603
  • [3] Cancer prevention: biomarkers and surrogate endpoints in clinical trials
    Greenberg, ER
    Hong, WK
    BIOMARKERS AND SURROGATE ENDPOINTS: CLINICAL RESEARCH AND APPLICATIONS, 2000, 1205 : 217 - 232
  • [4] Acute Kidney Injury Biomarkers and Endpoints for Clinical Trials
    Murray, Patrick T.
    HEMODIALYSIS: NEW METHODS AND FUTURE TECHNOLOGY, 2011, 171 : 208 - 212
  • [5] Optimizing Biomarkers and Endpoints in Oral Cancer Chemoprevention Trials
    William, William N., Jr.
    Papadimitrakopoulou, Vassiliki A.
    CANCER PREVENTION RESEARCH, 2013, 6 (05) : 375 - 378
  • [6] Biomarkers as Endpoints in Clinical Trials for Alzheimer's Disease
    Elghanam, Yomna
    Purja, Sujata
    Kim, Eun Young
    JOURNAL OF ALZHEIMERS DISEASE, 2024, 99 (02) : 693 - 703
  • [7] Biomarkers and cognitive endpoints to optimize trials in Alzheimer's disease
    Insel, Philip S.
    Mattsson, Niklas
    Mackin, R. Scott
    Kornak, John
    Nosheny, Rachel
    Tosun-Turgut, Duygu
    Donohue, Michael C.
    Aisen, Paul S.
    Weiner, Michael W.
    ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY, 2015, 2 (05): : 534 - 547
  • [8] Exploratory identification of predictive biomarkers in randomized trials with normal endpoints
    Krzykalla, Julia
    Benner, Axel
    Kopp-Schneider, Annette
    STATISTICS IN MEDICINE, 2020, 39 (07) : 923 - 939
  • [9] Biomarkers as surrogate endpoints in Alzheimer's disease clinical trials
    Kritsidima, M.
    Elferink, A. J.
    Wied, C. C. Gispen-de
    EUROPEAN JOURNAL OF NEUROLOGY, 2008, 15 : 33 - 33
  • [10] The Growing Need for Validated Biomarkers and Endpoints for Dry Eye Clinical Research
    Roy, Neeta S.
    Wei, Yi
    Kuklinski, Eric
    Asbell, Penny A.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2017, 58 (06) : BIO1 - BIO19
12345